The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention.

Neth Heart J · 2022 · PMC9123099 · PMID 35230636

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the bleeding rate was higher in patients treated with triple therapy than in those on dual therapy (18% vs 14%, p = 0.26), the difference did not reach statistical significance.

also in 111,027 other papers

a strong trendno p-value reported

Over the years, a strong trend towards more NOACs (14% in 2014 to 67% in 2019) and less triple therapy (62% in 2016 to 17% in 2019) was seen.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.